Location: Home > Pharma China Web Edition
  • search
  • go
  • Regulatory News
  • 12/31/2019NMPA Announces Initiation of Drug Business Application System
  • 12/31/2019NMPA Issues Guiding Principles for Classification Standards for ADRs o...
  • 12/30/2019NMPA Issues the Principles and Procedures for Drug Sampling
  • 12/27/2019NMPA Initiates Drug Import & Export Permit Management System
  • 12/26/2019China Lists Lemazolam for Regulation as Class 2 Psychotropic
  • 12/25/2019CDE Solicits Comments on Guidelines for Clinical Protocol of Biosimila...
  • 12/23/2019NMPA Issues the Technical Guidelines for Clinical Comparability Studie...
  • 12/17/2019NMPA/CDE Commits to CDISC Standards
  • 12/17/2019NMPA: China Has Over 1 Mln Registered Pharmacists
  • 12/13/2019NMPA and NHC Issues Joint Notice for Vaccine IT Tracing Infrastructura...
  • 12/13/2019Preview of 16 Heavy-weight New Drug Expected to be Approved in China N...
  • 12/12/2019ChP Commission Solicits Comments on the draft of “Naming Principles f...
  • 12/12/2019NMPA Issues the Guidelines for Aluminum Adjuvant in Preventative Vacci...
  • 12/10/2019SAMR Solicits Public Comments on the Provisions for Registration of Dr...
  • 12/6/2019NHSA Issues New Policy for Drug Price Regulation
  • 12/2/2019NMPA Announces Withdrawal of Additional 68 Certificate Requirements to...
  • 12/2/2019NMPA and NHC Jointly Issues the Provisions for Drug Clinical Trial Ins...
  • 12/2/2019NMPA Issues Notice on Relevant Matters for Implementation of the Drug ...
  • 11/29/2019NMPA Issues Implementation Plan for Reform Measures in Free Trade Pilo...
  • 11/29/2019Review of Import Registration of Originator Drugs
  • 11/27/2019China Opens Food & Drug Center of Excellence with Help of UNIDO
  • 11/26/2019CDE Solicits Comments on the Dispute Resolution Procedure for Drug Eva...
  • 11/22/2019NMPA Issues Implementation Guide for ICH E2B(R3) - Individual Case Saf...
  • 11/14/2019China to Launch Nationwide Vaccine Tracking System Next Year
  • 11/13/2019CDE Solicits Comments on the Working Procedures for Risk Control, Susp...
  • 11/12/2019NMPA Announces Implementation of 15 Series E and 13 Series S ICH Guide...
  • 11/11/2019CDE Extends Deadline for Public Comments on Nine Draft Documents
  • 11/11/2019CDE Solicits Comments on the Technical Guidelines for Clinical Researc...
  • 11/8/2019CDE Solicits Public Comments on the Working Process for Priority Revie...
  • 11/8/2019CDE Solicits Public Comments on the Working Process for Breakthrough M...
  • Page:8/9 Total number of articles:247: [First][<<] [5] [6] [7] [8] [9] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group Support by: www.heightow.com